html5-img
1 / 34

Global Venture Forum

Global Venture Forum. -the most effective way to find business partners in Japan-. BIO Industry in Japan. +Market Size+. 12.5 billion USD （ 2001 ）. 240.3 billion USD （ 2010 ）. Worldwide 2211.5 billion US$. Source: Overview of Biotechnology Strategy Council. USA 2884.6 billion US$.

luisa
Télécharger la présentation

Global Venture Forum

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Venture Forum -the most effective way to find business partners in Japan-

  2. BIO Industry in Japan +Market Size+ 12.5 billion USD （2001） 240.3 billion USD（2010） Worldwide 2211.5 billion US$ Source: Overview of Biotechnology Strategy Council USA 2884.6 billion US$ USA 28.8 trillion US$ Japan 240.3 billion US$ Europe 115.3 billion US$ Europe19.2 trillion US$ Japan 16.3 billion US$ Japan 12.5 billion US$ 2001 2003 2005 2010 2025

  3. The Bio Clusters in Japan Source: ‘The number of bio- venture companies in 2003’ by Japan Bioindustry Association Hokkaido the number of bio-ventures 45 Kanto Region the number of bio-ventures １９４ Kansai Region the number of bio-ventures 7７

  4. Biotechnology Industry in the Kansai Region Key Sectors: ■Pharmaceuticals ■Medical Instruments ■Functional Food

  5. Potential for the Pharmaceutical Sector in Kansai ■Pharmas in Kansai are concentrated in Osaka ‘Doshomachi’, the center of Osaka City. ■30% of Japan’s pharmaceutical-related companies and employees are concentrated in Kansai. ■Number of pharmas in Kansai, areequivalent to that of U.K. or France. ■Among the top 18 pharmas for sales in Japan, 8 have their headquarters in Kansai.

  6. 1. Takeda Pharmaceutical 2. Astellas (Yamanouchi + Fujisawa) 3. Sankyo + Daiichi 4. Eisai 5. Shionogi 6. * Chugai Pharmaceutical 7. Taisho Pharmaceutical 8. * Banyu Pharmaceutical 9. Tanabe Seiyaku 10. Otsuka Pharmaceutical 11. Novartis Pharma 12. Kyowa Hakko Kogyo 13. Ono Pharmaceutical 14. Mitsubishi Pharma 15. Sumitomo Pharmaceuticals 16. GlaxoSmithKline 17. Dainippon Pharmaceutical 18. TAIHO Pharmaceutical The Top 18 Pharmas in Japan By Amount of sales for drugs:2003

  7. Foreign Affiliated Bio-related companies in Kansai ■AstraZeneca Japan ■Eli Lilly Japan ■Schering-Plough K.K. ■Bayer Japan ■Boehringer Ingelheim ■Schering ■Organon Japan ■Nihon Medi-Physics ■Proctor & Gamble

  8. Concentration of Bio Research Institutions ■Osaka University (2,100 science researchers) ■Osaka University Hospital and Faculty of Medicine (advanced medical care:1,000beds) ■National Cardiovascular Center (100 researchers, 700beds) ■Osaka City University Medical School ■Osaka City University Medical School Hospital ■Osaka Bioscience Institute (40 researchers) ■Biomolecular Engineering Research Institute (60 researchers) ■Fundamental Technology Research Center for Studies on the Creation of New Medicines (more than 50 researchers)

  9. High-leveled Researches 1. Osaka University 2. Kyoto University 3. Okazaki National Research Institutes 4. Kobe University 5. Nagoya University 6. National Institute of Genetics 7. Tokyo University 8. Kyushu University 9. JICHI Medical School 10. Kyoto Prefectural University of Medicine

  10. Distinguished Researchers in Osaka ＜Immunology, Oncology＞ Tadamitsu KISHIMOTO, Osaka University Toshio HIRANO, Osaka University Shigekazu NAGATA, Osaka University ＜Biochemistry Neuroscience＞ Shigetada NAKANISHI, Kyoto University ＜Biochemistry＞ Yasutomi NISHIZUKA, Osaka University Masashi YANAGISAWA, Texas University (former Kyoto University) ＜Immunology Molecular Cell＞ Tetsuya TAGA, Kumamoto University (former Osaka University Professor) ＜Pharmacology Physiology＞ Tomoh MASAKI, Tsukuba University (former Kyoto University)

  11. Focused Diseases ■Arterial sclerosis ■Ischemic heart disease ■High-blood pressure ■Arthritis rheumatoides ■Asthma ■Atopic dermatitis ■Obesity ■Diabetes

  12. Market for the Medical Instrument Sector Source: Ministry of Health, Labor and Welfare ■Market Size in Japan 20 billion US$ (year 2002) 　⇒　2nd largest market in the world. 80 billion US$ (year 2010) Breakdown: ●medical-treatment related equipments 44.7% (PTCA catheter, pacemaker) ●diagnostic device 31.3% (endoscope, CT, MRI) ●others 24.0%

  13. Trends for Medical Care ■Changes in the Population Structure Aging Society ■Changes in the Disease Structure Acute Disease (infection) Chronic Disease (cancer, cardiac disorder, cerebrovascular disease, diabetes)

  14. Trends in Medical Care ■Changes in the quality of medical care examination & treatment prevention of disease curing technology Quality of Life

  15. Focused types of medical instruments Cardiovascular related Regeneration related Minimally invasive treatment Bio- Imaging Automotive diagnostic system Medical examination

  16. Internationalization ■Partnership with overseas companies technical tie-ups joint research and development

  17. Application for patents for medical instruments Number of applications for patents: 11,537 (year 2000) USA 64% Europe 27% Japan 9%

  18. Companies in Kansai Nipro Corporation SANYO Electric Biomedical Toyobo Co., Ltd. Teijin Kaneka Corporation Matsushita Electric Industrial Co., Ltd. Shimadzu Corporation OMRON Corporation Kyocera Corporation

  19. Market for the Functional Food Sector ■Market Size in Japan 4.2 billion USD (year 2003) 60 billion USD(year 2010) Source: Ministry of Economy, Trade and Industry

  20. Potential Market for the Functional Food Sector

  21. Companies in Kansai Suntory Limited Gekkeikan Glico Ikari Sauce Kaneka

  22. OCCI Activities for promotion of Bio-industry ■Study Group on Development of Functional Food ■Japan Bio-technology Business Competition ■BIO-Business School ■FORUM for Industrialization of Next Generation Medical Systems, Medical Treatment Systems ■NANO-BIO Industrialization Seminars ■BIO Information Highway Plan-Phase II ■Bio-Delegation to USA (June 20-26, 2005)

  23. Only Business Partnering event for foreign companies in Japan September 12th and 13th

  24. The Simple Concept +CONNECT+

  25. Business Partnering Service • GVF Secretariat Pre-Arranges individual business meetings before the event. • Search and contact the best suited company -> division -> personnel for the presenting technology. • Nation-Wide promotion • 12. 2 meetings per company (8.0 pre-arranged)

  26. Who’s in the Audience? • 161 Companies, 345 People (2004) List of Participants from the past event • Asahi Chemical Industry Co.,Ltd. • Shimadzu Corporation • SUNTORY LTD. • Sekisui Chemical Co.,Ltd. • KANEKA Corporation • Sumitomo Chemical Co.,Ltd. • Hitachi Chemical Co.,Ltd. • Toyobo Co.,Ltd. • Kuraray Co.,Ltd. • Nippon Paint Co.,Ltd. • Nippon Shokubai Co.,Ltd • Takeda Chemical Industries,LTD. • SHIONOGI & Co.,LTD. • Fujisawa Pharmaceutical Co.,Ltd. • Otsuka pharmaceutical Co.,Ltd.

  27. Result of Individual Meetings • 7 companies concluded or about to conclude Contracts. ( Technology tie ups, Joint Research, Joint Development, Finance, etc) • 10 companies continues their business discussions. • 0 company had no specific result

  28. Only Companies with excellent technology are allowed to participate after the evaluation by Nominating Committee. Main criteria : Creativity of Technology and Marketability of Products in Japan. Quality First

  29. Success Stories from GVF03 ■Software company from USA made a distribution agreement with a major software distributor in Japan ■Agribio company from Japan, producing UBS Soil Activator received investment from an industrial promotion organization in Japan. ■A bio-tech company from Japan, developing innovative technology to develop oral agents for drugs considered difficult for oral absorption, received investment from an investment firm.

  30. Process • Application Deadline • Screening Committee Meeting & Notification to Presenters • Audience Recruiting • Payment Deadline for Participation Fee • Presenter’s Orientation • GVF05-BIO May 20th June 20th Mid-July July 29th September 11th September 12th-13th

  31. US$1,500- Participation Fee • ---The Fee Covers---- • Business Match-making Service • Individual Booth ( W3.0 x L1.5 x H1.5 in meters ) • Simultaneous Interpretation for Presentation • A Professional Interpreter for business talks for 2days • Invitation to all GVF related events • Nation wide promotion

  32. Incentives and a 1-Day Industrial Trip in Kansai ■Incentives by the Osaka City Government(tentative) For companies planning to set up a business base in Osaka City, there is a chance to receive refund of the GVF05 Participation Fee from the IBPC Osaka Investment Promotion Center. ■ 1-Day Industrial Trip by METI-Kansai (tentative) The METI-Kansai is planning to hold another industrial trip again for the GVF Participants after the GVF05-BIO event.

  33. How to Apply • Submit necessary documentations to appropriate secretariat or coordinator via E-mail • Template file of Application form can be downloaded from the WEB http://www.gvf.ne.jp/ • Attachment of Presentation helps

  34. Thank you very much!! For further details and questions Please contact Ryoichi Nakanotel: +81-6-6944-6403e-mail: gvf@osaka.cci.or.jp http://www.gvf.or.jp/e

More Related